Insider Transactions in Q4 2022 at Meridian Bioscience Inc (VIVO)
Insider Transaction List (Q4 2022)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Dec 06
2022
|
Julie Diana Smith Sr VP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
374
-1.23%
|
$11,594
$31.71 P/Share
|
Nov 15
2022
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
4,382
-5.31%
|
$135,842
$31.83 P/Share
|
Nov 15
2022
|
Tony Serafini Lamanna Executive VP-Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
3,666
-9.39%
|
$113,646
$31.83 P/Share
|
Nov 15
2022
|
Julie Diana Smith Sr VP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,845
-5.72%
|
$57,195
$31.83 P/Share
|
Nov 04
2022
|
Lourdes Weltzien Executive VP, Life Science |
SELL
Payment of exercise price or tax liability
|
Direct |
566
-0.68%
|
$18,112
$32.01 P/Share
|
Nov 04
2022
|
Julie Diana Smith Sr VP, Controller, PAO |
SELL
Payment of exercise price or tax liability
|
Direct |
397
-1.22%
|
$12,704
$32.01 P/Share
|
Nov 04
2022
|
John P. Kenny Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,271
-1.9%
|
$136,672
$32.01 P/Share
|
Nov 04
2022
|
Tony Serafini Lamanna Executive VP-Diagnostics |
SELL
Payment of exercise price or tax liability
|
Direct |
788
-1.98%
|
$25,216
$32.01 P/Share
|
Oct 03
2022
|
John P. Kenny Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
40,269
-15.19%
|
$1,248,339
$31.53 P/Share
|